• CM Hospitalar, operating as Viveo, renegotiated debentures, extending the amortization schedule and adjusting covenants to strengthen liquidity.
• Operating margins expanded for six consecutive quarters, with EBITDA growth and structural improvements in profitability.
• Cash generation reached a record in 2025, followed by an unprecedented first-quarter level in 2026.
• The commercial strategy prioritizes profitability and sustainable cash generation over volume growth, with margins returning to 2023 levels.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CM Hospitalar SA published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.